Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10450275
Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
granted -
US 10442852
Methods and compositions for treatment of symptoms associated with intracranial hemorrhage
granted -
US 10442911
Dendritic macroporous hydrogels prepared by crystal templating
granted -
US 10442182
In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing
granted -
US 10441607
Multifunctional linker technology containing an N4 group
granted -
US 10434075
FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer
granted -
US 10434062
Compositions and methods of making brittle-matrix particles through blister pack freezing
granted -
US 10434063
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted -
US 10428159
Blocking monoclonal antibodies to AGR2 and its receptor C4.4A
granted -
US 10428057
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
granted -
US 10420758
Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof
granted -
US 10421765
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
granted -
US 10420833
Combinatorial platform for the display of surface adjuvants and antigens
granted -
US 10420720
Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
granted -
US 10406167
Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance
granted -
US 10398661
Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers
granted -
US 10398682
Methods and compositions to prevent or treat bacterial infections
granted -
US 10392376
Heterocyclic inhibitors of ATR kinase
granted -
US 10391126
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 10392618
Micro-RNA family that modulates extracellular matrix genes and uses thereof
granted -
US 10391098
Antisense antibacterial compounds and methods
granted -
US 10391183
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
granted -
US 10385080
STAT6 inhibitors
granted -
US 10383940
Copper-cysteamine and methods of use
granted